Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With

Jane E Whitney1,2, Binqing Zhang1, Natalka Koterba3,4,5

  • 1Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

Critical Care Medicine
|February 15, 2020
PubMed

Insights

Children with sepsis and acute respiratory distress syndrome show higher endothelial activation biomarkers. These markers, including angiopoietin-2 and von Willebrand factor, indicate a higher risk of complicated sepsis outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Sepsis research
  • Endothelial biology

Background:

  • Systemic endothelial activation is implicated in sepsis-associated organ injury, including acute respiratory distress syndrome (ARDS).
  • Understanding endothelial activation in pediatric extrapulmonary sepsis is crucial for predicting outcomes.

Purpose of the Study:

  • To investigate plasma biomarkers of endothelial activation in children with extrapulmonary sepsis, comparing those with and without ARDS.
  • To determine if persistent biomarker changes correlate with poor outcomes in pediatric sepsis.

Main Methods:

  • An observational cohort study was conducted in an academic pediatric intensive care unit (PICU).
  • Plasma samples were collected from children with extrapulmonary sepsis (with or without ARDS) and noninfected controls at multiple time points.
  • A panel of endothelial and inflammatory biomarkers was measured and analyzed in relation to ARDS presence and clinical course.

Main Results:

  • Patients with sepsis and ARDS exhibited significantly higher levels of angiopoietin-2, vascular endothelial growth factor, vascular cell adhesion molecule, and other biomarkers compared to those without ARDS.
  • Several baseline endothelial biomarkers, including angiopoietin-2 and von Willebrand factor, were associated with a complicated sepsis course.
  • Longitudinal changes in biomarkers provided prognostic information primarily in sepsis patients without ARDS.

Conclusions:

  • Pediatric patients with extrapulmonary sepsis and ARDS demonstrate heightened systemic endothelial activation.
  • Specific endothelial biomarkers measured early in sepsis are predictive of a complicated clinical course.
  • The prognostic value of longitudinal biomarker trends differs between sepsis with and without ARDS.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
934
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
379
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
726
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
462
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
678
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
426